Back
Corcept Therapeutics Stock Price Chart
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Buy
78
CORT
Corcept Therapeutics
Last Price:
56.09
Seasonality Move:
2.29%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.37 | Buy |
| 20-day SMA: | 52.39 | Buy |
| 50-day SMA: | 47.38 | Buy |
| 200-day SMA: | 33.34 | Buy |
| 8-day EMA: | 54.58 | Buy |
| 20-day EMA: | 52.72 | Buy |
| 50-day EMA: | 47.93 | Buy |
| 200-day EMA: | 36.85 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.41 | Buy |
| Relative Strength Index (14 RSI): | 62.02 | Buy |
| Chaikin Money Flow: | 911392 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.68 - 55.6) | Buy |
| Bollinger Bands (100): | (32.78 - 48.56) | Buy |
Corcept Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
- Corcept Therapeutics share price is 56.09 while CORT 8-day simple moving average is 55.37, which is a Buy signal.
- The stock price of CORT is 56.09 while Corcept Therapeutics 20-day SMA is 52.39, which makes it a Buy.
- Corcept Therapeutics 50-day simple moving average is 47.38 while CORT share price is 56.09, making it a Buy technically.
- CORT stock price is 56.09 and Corcept Therapeutics 200-day simple moving average is 33.34, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
78
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a Buy
The current Corcept Therapeutics [CORT] share price is $56.09. The Score for CORT is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
5.88B
Price in USD:
56.09
Share Volume:
947.31K
Corcept Therapeutics 52-Week Range
52-Week High:
61.66
52-Week Low:
20.84
Buy
78
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?
The Corcept Therapeutics stock price is 56.09 USD today. -
Will CORT stock go up or go down?
Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Corcept Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
- Corcept Therapeutics share price is 56.09 while CORT 8-day exponential moving average is 54.58, which is a Buy signal.
- The stock price of CORT is 56.09 while Corcept Therapeutics 20-day EMA is 52.72, which makes it a Buy.
- Corcept Therapeutics 50-day exponential moving average is 47.93 while CORT share price is 56.09, making it a Buy technically.
- CORT stock price is 56.09 and Corcept Therapeutics 200-day simple moving average is 36.85, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
- CORT Moving Average Covergence Divergence (MACD) indicator is 2.41, suggesting Corcept Therapeutics is a Buy
- Corcept Therapeutics Relative Strength Index (RSI) is 62.02, which suggest Corcept Therapeutics is overbought
- The Bollinger Bands (25) for Corcept Therapeutics is (47.68 - 55.6), which suggest Corcept Therapeutics is a Buy
- The Bollinger Bands (100) for Corcept Therapeutics is (32.78 - 48.56), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.